IBDEI130 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19088,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,19088,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,19089,0)
 ;;=780.39^^105^1227^103
 ;;^UTILITY(U,$J,358.3,19089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19089,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,19089,1,5,0)
 ;;=5^Seizure
 ;;^UTILITY(U,$J,358.3,19089,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,19090,0)
 ;;=782.0^^105^1227^87
 ;;^UTILITY(U,$J,358.3,19090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19090,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,19090,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,19090,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,19091,0)
 ;;=435.9^^105^1227^107
 ;;^UTILITY(U,$J,358.3,19091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19091,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,19091,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,19091,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,19092,0)
 ;;=354.2^^105^1227^109
 ;;^UTILITY(U,$J,358.3,19092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19092,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,19092,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,19092,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,19093,0)
 ;;=729.1^^105^1227^35
 ;;^UTILITY(U,$J,358.3,19093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19093,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,19093,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,19093,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,19094,0)
 ;;=438.20^^105^1227^11
 ;;^UTILITY(U,$J,358.3,19094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19094,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,19094,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,19094,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,19095,0)
 ;;=438.12^^105^1227^8
 ;;^UTILITY(U,$J,358.3,19095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19095,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,19095,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,19095,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,19096,0)
 ;;=356.8^^105^1227^90
 ;;^UTILITY(U,$J,358.3,19096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19096,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,19096,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,19096,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,19097,0)
 ;;=337.20^^105^1227^100
 ;;^UTILITY(U,$J,358.3,19097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19097,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,19097,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,19097,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,19098,0)
 ;;=294.8^^105^1227^33
 ;;^UTILITY(U,$J,358.3,19098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19098,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,19098,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,19098,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,19099,0)
 ;;=438.6^^105^1227^7
 ;;^UTILITY(U,$J,358.3,19099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19099,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,19099,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,19099,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,19100,0)
 ;;=438.7^^105^1227^26
 ;;^UTILITY(U,$J,358.3,19100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19100,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,19100,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,19100,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,19101,0)
 ;;=438.84^^105^1227^5
 ;;^UTILITY(U,$J,358.3,19101,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI130
